Beijing Aosaikang Pharmaceutical Co., Ltd.

SZSE:002755 Stock Report

Market Cap: CN¥16.7b

Beijing Aosaikang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Beijing Aosaikang Pharmaceutical has a total shareholder equity of CN¥3.2B and total debt of CN¥47.0M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.2B and CN¥1.0B respectively. Beijing Aosaikang Pharmaceutical's EBIT is CN¥114.8M making its interest coverage ratio -4.4. It has cash and short-term investments of CN¥2.3B.

Key information

1.46%

Debt to equity ratio

CN¥47.00m

Debt

Interest coverage ratio-4.4x
CashCN¥2.28b
EquityCN¥3.23b
Total liabilitiesCN¥1.02b
Total assetsCN¥4.25b

Recent financial health updates

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) A Risky Investment?

Mar 05
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) A Risky Investment?

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Oct 11
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

Apr 29
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

Recent updates

Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Shares Climb 25% But Its Business Is Yet to Catch Up

Mar 16
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Shares Climb 25% But Its Business Is Yet to Catch Up

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) A Risky Investment?

Mar 05
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) A Risky Investment?

A Look At The Fair Value Of Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755)

Feb 11
A Look At The Fair Value Of Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755)

Some Confidence Is Lacking In Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) P/S

Jan 17
Some Confidence Is Lacking In Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) P/S

Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking

Oct 18
Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Oct 11
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?

Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem

Sep 05
Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem

Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

May 21
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues

Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

Apr 29
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?

There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Mar 13
There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump

Financial Position Analysis

Short Term Liabilities: 002755's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥939.9M).

Long Term Liabilities: 002755's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥83.7M).

Debt to Equity History and Analysis

Debt Level: 002755 has more cash than its total debt.

Reducing Debt: 002755's debt to equity ratio has increased from 0% to 1.5% over the past 5 years.

Debt Coverage: 002755's debt is well covered by operating cash flow (854.2%).

Interest Coverage: 002755 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/07 08:39
End of Day Share Price 2025/07/07 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Beijing Aosaikang Pharmaceutical Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shitong HanCitic Securities Co., Ltd.
Yinhao TangCitic Securities Co., Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd